ROYAL BANK OF CANADA - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 105 filers reported holding EIDOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$6,000
+200.0%
48
-2.0%
0.00%
Q1 2020$2,000
-71.4%
49
-64.0%
0.00%
Q4 2019$7,000
+250.0%
136
+166.7%
0.00%
Q3 2019$2,0000.0%510.0%0.00%
Q2 2019$2,000
+100.0%
510.0%0.00%
Q1 2019$1,000
-75.0%
51
-79.3%
0.00%
Q4 2018$4,000
+33.3%
246
-25.2%
0.00%
Q3 2018$3,0003290.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders